The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Clinical Trial Market Research Report 2024
Synopsis
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The global Clinical Trial market was valued at US$ 46670 million in 2023 and is anticipated to reach US$ 84800 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial.
Report Scope
The Clinical Trial market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Trial market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fisher Clinical Services
Myoderm
Bilcare
CliniChain
Ancillare
MESM
ERG Holding
Apex Medical Research
Parexel
PRA Health
LabCorp (Covance)
Marken
AmerisourceBergen (World Courier)
Segment by Type
Instruments(Products)
Consumables
Others
Segment by Application
Procurement and Supplies
Rentals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The global Clinical Trial market was valued at US$ 46670 million in 2023 and is anticipated to reach US$ 84800 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial.
Report Scope
The Clinical Trial market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Trial market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fisher Clinical Services
Myoderm
Bilcare
CliniChain
Ancillare
MESM
ERG Holding
Apex Medical Research
Parexel
PRA Health
LabCorp (Covance)
Marken
AmerisourceBergen (World Courier)
Segment by Type
Instruments(Products)
Consumables
Others
Segment by Application
Procurement and Supplies
Rentals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments(Products)
1.2.3 Consumables
1.2.4 Others
1.3 Market by Application
1.3.1 Global Clinical Trial Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Procurement and Supplies
1.3.3 Rentals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Market Perspective (2019-2030)
2.2 Clinical Trial Growth Trends by Region
2.2.1 Global Clinical Trial Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Trial Historic Market Size by Region (2019-2024)
2.2.3 Clinical Trial Forecasted Market Size by Region (2025-2030)
2.3 Clinical Trial Market Dynamics
2.3.1 Clinical Trial Industry Trends
2.3.2 Clinical Trial Market Drivers
2.3.3 Clinical Trial Market Challenges
2.3.4 Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Players by Revenue
3.1.1 Global Top Clinical Trial Players by Revenue (2019-2024)
3.1.2 Global Clinical Trial Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial Revenue
3.4 Global Clinical Trial Market Concentration Ratio
3.4.1 Global Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Revenue in 2023
3.5 Clinical Trial Key Players Head office and Area Served
3.6 Key Players Clinical Trial Product Solution and Service
3.7 Date of Enter into Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Breakdown Data by Type
4.1 Global Clinical Trial Historic Market Size by Type (2019-2024)
4.2 Global Clinical Trial Forecasted Market Size by Type (2025-2030)
5 Clinical Trial Breakdown Data by Application
5.1 Global Clinical Trial Historic Market Size by Application (2019-2024)
5.2 Global Clinical Trial Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Trial Market Size (2019-2030)
6.2 North America Clinical Trial Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Trial Market Size by Country (2019-2024)
6.4 North America Clinical Trial Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Market Size (2019-2030)
7.2 Europe Clinical Trial Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Trial Market Size by Country (2019-2024)
7.4 Europe Clinical Trial Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Market Size (2019-2030)
8.2 Asia-Pacific Clinical Trial Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Trial Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Trial Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial Market Size (2019-2030)
9.2 Latin America Clinical Trial Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Trial Market Size by Country (2019-2024)
9.4 Latin America Clinical Trial Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Market Size (2019-2030)
10.2 Middle East & Africa Clinical Trial Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Trial Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Trial Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fisher Clinical Services
11.1.1 Fisher Clinical Services Company Detail
11.1.2 Fisher Clinical Services Business Overview
11.1.3 Fisher Clinical Services Clinical Trial Introduction
11.1.4 Fisher Clinical Services Revenue in Clinical Trial Business (2019-2024)
11.1.5 Fisher Clinical Services Recent Development
11.2 Myoderm
11.2.1 Myoderm Company Detail
11.2.2 Myoderm Business Overview
11.2.3 Myoderm Clinical Trial Introduction
11.2.4 Myoderm Revenue in Clinical Trial Business (2019-2024)
11.2.5 Myoderm Recent Development
11.3 Bilcare
11.3.1 Bilcare Company Detail
11.3.2 Bilcare Business Overview
11.3.3 Bilcare Clinical Trial Introduction
11.3.4 Bilcare Revenue in Clinical Trial Business (2019-2024)
11.3.5 Bilcare Recent Development
11.4 CliniChain
11.4.1 CliniChain Company Detail
11.4.2 CliniChain Business Overview
11.4.3 CliniChain Clinical Trial Introduction
11.4.4 CliniChain Revenue in Clinical Trial Business (2019-2024)
11.4.5 CliniChain Recent Development
11.5 Ancillare
11.5.1 Ancillare Company Detail
11.5.2 Ancillare Business Overview
11.5.3 Ancillare Clinical Trial Introduction
11.5.4 Ancillare Revenue in Clinical Trial Business (2019-2024)
11.5.5 Ancillare Recent Development
11.6 MESM
11.6.1 MESM Company Detail
11.6.2 MESM Business Overview
11.6.3 MESM Clinical Trial Introduction
11.6.4 MESM Revenue in Clinical Trial Business (2019-2024)
11.6.5 MESM Recent Development
11.7 ERG Holding
11.7.1 ERG Holding Company Detail
11.7.2 ERG Holding Business Overview
11.7.3 ERG Holding Clinical Trial Introduction
11.7.4 ERG Holding Revenue in Clinical Trial Business (2019-2024)
11.7.5 ERG Holding Recent Development
11.8 Apex Medical Research
11.8.1 Apex Medical Research Company Detail
11.8.2 Apex Medical Research Business Overview
11.8.3 Apex Medical Research Clinical Trial Introduction
11.8.4 Apex Medical Research Revenue in Clinical Trial Business (2019-2024)
11.8.5 Apex Medical Research Recent Development
11.9 Parexel
11.9.1 Parexel Company Detail
11.9.2 Parexel Business Overview
11.9.3 Parexel Clinical Trial Introduction
11.9.4 Parexel Revenue in Clinical Trial Business (2019-2024)
11.9.5 Parexel Recent Development
11.10 PRA Health
11.10.1 PRA Health Company Detail
11.10.2 PRA Health Business Overview
11.10.3 PRA Health Clinical Trial Introduction
11.10.4 PRA Health Revenue in Clinical Trial Business (2019-2024)
11.10.5 PRA Health Recent Development
11.11 LabCorp (Covance)
11.11.1 LabCorp (Covance) Company Detail
11.11.2 LabCorp (Covance) Business Overview
11.11.3 LabCorp (Covance) Clinical Trial Introduction
11.11.4 LabCorp (Covance) Revenue in Clinical Trial Business (2019-2024)
11.11.5 LabCorp (Covance) Recent Development
11.12 Marken
11.12.1 Marken Company Detail
11.12.2 Marken Business Overview
11.12.3 Marken Clinical Trial Introduction
11.12.4 Marken Revenue in Clinical Trial Business (2019-2024)
11.12.5 Marken Recent Development
11.13 AmerisourceBergen (World Courier)
11.13.1 AmerisourceBergen (World Courier) Company Detail
11.13.2 AmerisourceBergen (World Courier) Business Overview
11.13.3 AmerisourceBergen (World Courier) Clinical Trial Introduction
11.13.4 AmerisourceBergen (World Courier) Revenue in Clinical Trial Business (2019-2024)
11.13.5 AmerisourceBergen (World Courier) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
